abstract |
Inhibitors of matrix metalloproteinase 2 are used to treat or prevent a fϊbrotic disorder of the posterior capsule of the eye, for example posterior capsule opacification (PCO), or of a tissue or structure of the eye other than the lens or capsular bag. |